How big is the Advanced Therapy Medicinal Products CDMO Market?

The Advanced Therapy Medicinal Products CDMO Market size is expected to reach USD 6.04 billion in 2024 and grow at a CAGR of 24.40% to reach USD 17.98 billion by 2029. Read More

What is the current Advanced Therapy Medicinal Products CDMO Market size?

In 2024, the Advanced Therapy Medicinal Products CDMO Market size is expected to reach USD 6.04 billion. Read More

Who are the key players in Advanced Therapy Medicinal Products CDMO Market?

Catalent, Inc., Lonza, WuXi Advanced Therapies, AGC Biologics and CELONIC Group are the major companies operating in the Advanced Therapy Medicinal Products CDMO Market. Read More

Which is the fastest growing region in Advanced Therapy Medicinal Products CDMO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Advanced Therapy Medicinal Products CDMO Market?

In 2024, the North America accounts for the largest market share in Advanced Therapy Medicinal Products CDMO Market. Read More

What years does this Advanced Therapy Medicinal Products CDMO Market cover, and what was the market size in 2023?

In 2023, the Advanced Therapy Medicinal Products CDMO Market size was estimated at USD 4.57 billion. The report covers the Advanced Therapy Medicinal Products CDMO Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Advanced Therapy Medicinal Products CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Advanced Therapy Medicinal Products (ATMP) CDMO Market Share

Statistics for the 2023 & 2024 Advanced Therapy Medicinal Products (ATMP) CDMO market share, created by Mordor Intelligence™ Industry Reports. Advanced Therapy Medicinal Products (ATMP) CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Advanced Therapy Medicinal Products (ATMP) CDMO Industry

The advanced therapy medicinal products (ATMP) CDMO market is moderately competitive, with several international players. Companies are involved in strategic activities like partnerships and collaboration to sustain the market. Some of the key players in the market include Catalent Inc., Lonza, WuXi Advanced Therapies, AGC Biologics, and CELONIC Group.